KN
Kiniksa Pharmaceuticals International, plc
KNSA · NASDAQ
$77.09 +0.97% (+$0.74)
1M +1.80%
Market Cap $6.13B
P/E Ratio 76.03x
Div. Yield -
ROE 13.65%
Bulios Fair Price
$49.4
35.9% downside
Trenutna cena
$77.09
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KNSA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
12 /100
Expensive P/E 76.03x
EV/EBITDA 53.22x
P/S 7.29x
Growth
69 /100
Growing EPS growth 33.93%
Rev. growth 45.45%
FCF growth 64.56%
Profitability
78 /100
Strong Gross margin 54.49%
Net margin 9.59%
Op. margin 11.92%
Quality
64 /100
Average ROIC 9.71%
ROE 13.65%
ROA 9.00%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 3.90x
Net debt/EBITDA -1.49x
Stability
19 /100
Unstable Beta 0.09x
Rev. volatility 20.63%
EPS volatility 312.51%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KNSA
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Sanj K. Patel
Employees
366
Headquarters
London
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report